Acasă › Insuficiență cardiacă › Missouri › Kansas City
Studii clinice pentru Insuficiență cardiacă în Kansas City, MO
25 studii pentru Insuficiență cardiacă caută participanți în și în jurul orașului Kansas City (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
ELEVATE-HFpEF Clinical Study
În curs de recrutare
- Saint Lukes Mid America Heart Institute, Kansas City
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
În curs de recrutareFaza 3
- Research Site, Kansas City
- Research Site, Kansas City
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
În curs de recrutareFaza 3
- Kansas City VA Medical Center, Kansas City
- North Kansas City Hospital, North Kansas City · La 2 mi distanță
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
În curs de recrutareFaza 3
- Kansas City VA Medical Center, Kansas City
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
În curs de recrutareFaza 3
- Research Site, Kansas City
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
În curs de recrutareFaza 3
- Saint Luke's Hospital of Kansas City, Kansas City
Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure
În curs de recrutare
- Saint Luke's Hospital of Kansas City, Kansas City
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
În curs de recrutareFaza 3
- Saint Luke's Hospital of Kansas City, Kansas City
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
În curs de recrutareFaza 3
- Research Site, Kansas City
- Research Site, Kansas City
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
În curs de recrutareFaza 3
- Kansas City, MO Investigative Site 10002, Kansas City
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
În curs de recrutareFaza 3
- CON-10002 Kansas City, MO Investigative Site, Kansas City
The WiSE®-UP Study (The WiSE System Utilization & Performance Study)
În curs de recrutareStudiu observațional
- St. Luke's Hospital of Kansas City, Kansas City
A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
În curs de recrutareFaza 2
- Local Institution - 145, Kansas City
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
În curs de recrutareStudiu observațional
- Kansas City, Kansas City
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
În curs de recrutareStudiu observațional
- St. Luke's Mid-America Heart Institute, Kansas City
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
În curs de recrutareFaza 3
- Tenax Investigational Site, Kansas City
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
În curs de recrutareFaza 3
- Clinical Research Consultants, JCCT Co, Kansas City
Assessment of CCM in HF With Higher Ejection Fraction
În curs de recrutare
- St. Lukes Hospital Kansas City (Mid America Heart Institute), Kansas City
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
În curs de recrutareFaza 3
- FIN-10002 Kansas City, MO Investigational Site, Kansas City
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
În curs de recrutare
- St. Lukes/ Mid-American Heart Institute, Kansas City
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
În curs de recrutareFaza 3
- Children's Mercy Hospital Kansas City - Cardiology, Kansas City
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
În curs de recrutareFaza 3
- Children's Mercy Hospital Kansas City - Cardiology, Kansas City
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
În curs de recrutare
- St. Luke's Hospital, Kansas City
CCM OPEN HF Registry
În curs de recrutareStudiu observațional
- Saint Luke's Hospital Mid America Heart Institute, Kansas City
- Saint Luke's Hospital of Kansas City, Kansas City
HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry
În curs de recrutareStudiu observațional
- Saint Luke's Health System, Kansas City
Studii pentru Insuficiență cardiacă în alte orașe
- New York City, NY51 studii
- Boston, MA44 studii
- Dallas, TX42 studii
- Houston, TX36 studii
- Cleveland, OH33 studii
- Chicago, IL31 studii
- Philadelphia, PA31 studii
- San Francisco, CA29 studii
- Durham, NC26 studii
- St. Louis, MO26 studii
- Atlanta, GA25 studii
- Cincinnati, OH24 studii
Alte studii în Kansas City
- Cancer de sân34 studii
- Cancer pulmonar cu celule non-pătrate31 studii
- Cancer (toate tipurile)21 studii
- Cancer pulmonar19 studii
- Cancer colorectal16 studii
- Cancer metastatic15 studii
- Leucemie mieloasă acută15 studii
- Cancer de prostată14 studii
- Cancer ovarian11 studii
- Obezitate11 studii
- Diabet de tip 211 studii
- Boli cardiovasculare11 studii
Sursă: ClinicalTrials.gov, date preluate la 6 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.